A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Oncology

Background:

• Genotoxic compounds can cause DNA damage, leading to cell death.
• Selective toxicity is crucial for minimizing harm to healthy cells.
• Targeting specific cellular components can enhance drug efficacy.

Purpose of the Study:

• To develop a novel strategy for increasing the selective toxicity of genotoxic compounds.
• To synthesize bifunctional molecules that form DNA adducts with high affinity for specific proteins.
• To investigate the potential of such compounds to compromise protein function and DNA repair, thereby increasing toxicity.

Main Methods:

• Synthesis of a bifunctional compound linking an aniline mustard to estradiol at the 7alpha position.
• Assessment of the compound's ability to form covalent DNA adducts with high affinity for the estrogen receptor.
• Evaluation of the cytotoxic effects on breast cancer cells expressing varying levels of the estrogen receptor.

Main Results:

• A novel bifunctional compound was successfully synthesized.
• The compound forms DNA adducts with high affinity for the estrogen receptor.
• Breast cancer cells with high estrogen receptor expression demonstrated increased sensitivity to the compound's cytotoxic effects.

Conclusions:

• The developed strategy effectively increases the selective toxicity of genotoxic compounds.
• Bifunctional molecules targeting specific proteins, like the estrogen receptor, show promise for cancer therapy.
• This approach offers a potential method for enhanced treatment of estrogen receptor-positive cancers.